These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6105079)

  • 1. Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays.
    Sotaniemi EA; Pelkonen RO; Puukka M
    Eur J Clin Pharmacol; 1980 Apr; 17(4):267-74. PubMed ID: 6105079
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic enzyme induction and its relationship to urinary D-glucaric acid excretion in man.
    Lecamwasam DS
    Br J Clin Pharmacol; 1975 Dec; 2(6):546-8. PubMed ID: 1234021
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin.
    Ohnhaus EE; Kirchhof B; Peheim E
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):591-7. PubMed ID: 35298
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modification of the action of drugs by inhibition of their metabolism].
    Park BK; Breckenridge AM; Ohnhaus EE
    Recenti Prog Med; 1979 Sep; 67(3):313-45. PubMed ID: 42953
    [No Abstract]   [Full Text] [Related]  

  • 5. Research on the eventual enzymatic induction activity of cetiedil in rat and man.
    Larousse C; Kergueris MF; Le Normand Y; Visset J
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):195-9. PubMed ID: 7390670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.
    Ohnhaus EE; Park BK
    Eur J Clin Pharmacol; 1979 Mar; 15(2):139-45. PubMed ID: 35353
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man.
    Lecamwasam DS; Franklin C; Turner P
    Br J Clin Pharmacol; 1975 Jun; 2(3):257-62. PubMed ID: 1234506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of anticonvulsant drugs to cytochrome P-450: correlation with evidence of induction of hepatic microsomal enzymes.
    Latham AN; Sweeney GD
    Can J Physiol Pharmacol; 1976 Dec; 54(6):844-9. PubMed ID: 1021219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between lipid composition and drug metabolizing capacity of human liver.
    Savolainen MJ; Arranto AJ; Hassinen IE; Luoma PV; Pelkonen RO; Sotaniemi EA
    Eur J Clin Pharmacol; 1985; 27(6):727-32. PubMed ID: 3987778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical urinary excretion of D-glucaric acid in acute viral hepatitis.
    Sorrell MF; Burnett DA; Tuma DJ; Barak AJ
    Clin Pharmacol Ther; 1976 Sep; 20(3):365-8. PubMed ID: 954355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver size and indices of drug metabolism in alcoholics.
    Pirttiaho HI; Sotaniemi EA; Ahlqvist J; Pitkänen U; Pelkonen RO
    Eur J Clin Pharmacol; 1978 Mar; 13(1):61-7. PubMed ID: 639835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological changes in the liver and indices of drug metabolism in alcoholics.
    Sotaniemi EA; Ahlqvist J; Pelkonen RO; Pirttiaho H; Luoma PV
    Eur J Clin Pharmacol; 1977 Apr; 11(4):295-303. PubMed ID: 862651
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of age and of the inducer phenobarbital on the cytochrome P-450 dependent monooxygenation of drugs in rat liver.
    Müller D; Klinger W
    Pharmazie; 1978 Jul; 33(7):397-400. PubMed ID: 103104
    [No Abstract]   [Full Text] [Related]  

  • 14. Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.
    Perry W; Jenkins MV
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):609-13. PubMed ID: 3793294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term preservation and induction of drug metabolizing enzymes in co-cultured rat hepatocytes.
    Akrawi M; Rogiers V; Vercruysse A; Phillips IR; Shephard EA
    Biochem Soc Trans; 1994 May; 22(2):124S. PubMed ID: 7958195
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary D-glucaric acid excretion during rifampicin/isoniazid and anticonvulsant enzyme induction.
    Perry W; Stamp TC
    Clin Pharmacol Ther; 1984 May; 35(5):710-5. PubMed ID: 6143635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug metabolism in man: in vivo and in vitro correlations.
    Sotaniemi EA; Pelkonen RO; Ahokas J; Ahlqvist J; Hokkanen OT
    Arch Toxicol Suppl; 1978; (1):339-42. PubMed ID: 277127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of enzyme induction and enzyme inhibition.
    Park BK; Breckenridge AM
    Clin Pharmacokinet; 1981; 6(1):1-24. PubMed ID: 6113907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medroxyprogesterone acetate does not induce antipyrine clearance and only weakly increases alpha 1-acid glycoprotein in beagle dogs.
    Abramson FP; Moore CF; Hill MD
    Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):65-78. PubMed ID: 2944196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of age and diet on the induction of hexobarbital-metabolizing enzymes in the mouse.
    Hospador MA; Manthei RW
    Proc Soc Exp Biol Med; 1968 May; 128(1):130-2. PubMed ID: 4385350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.